Postoperative Radiotherapy Favorable as Adjuvant Treatment for Thymic Neuroendocrine Tumors
A propensity-score matched analysis was used to determine the effect of surgery and postoperative radiotherapy in patients with TNETs.
A propensity-score matched analysis was used to determine the effect of surgery and postoperative radiotherapy in patients with TNETs.
An existing antibody cocktail commonly used for pathology tests of the uterine cervix can be used to test for recurrent cancer.
Sunitinib, an agent approved for use in several cancers, could prove useful in treatment of thymic carcinoma when traditional chemotherapy fails.